Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 218 entries
View as:

Investigating the Safety of LEO 158968 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05682352 Org: User:
Start: 02/07/23 End: 08/01/24 Due: 08/01/25

Body PSOriasis: Long-term Relapse CONTROL

Phase: N/A Priority: Normal
NCT ID: NCT03402828 Org: User:
Start: 06/11/18 End: 05/15/20 Due: 05/15/21

Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.

Phase: N/A Priority: Normal
NCT ID: NCT01268774 Org: User:
Start: 02/28/09 End: 07/31/11 Due: 07/31/12

Real-life Evaluation of the Daivobet® Gel Applicator

Phase: N/A Priority: Normal
NCT ID: NCT02856542 Org: User:
Start: 05/23/16 End: 06/30/17 Due: 06/30/18

Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT01257919 Org: User:
Start: 01/31/11 End: 03/31/11 Due: 03/31/12

The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02594436 Org: User:
Start: 12/01/15 End: 11/30/17 Due: 11/30/18

Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01707368 Org: User:
Start: 10/31/12 End: 07/31/14 Due: 07/31/15

A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis

Phase: N/A Priority: Normal
NCT ID: NCT03788863 Org: User:
Start: 11/16/18 End: 11/29/18 Due: 11/29/19

Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT02090465 Org: User:
Start: 07/31/13 End: 12/31/13 Due: 12/31/14

Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT03126578 Org: User:
Start: 05/31/17 End: 10/20/17 Due: 10/20/18

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT01025635 Org: User:
Start: 12/31/09 End: 08/31/10 Due: 08/31/11

Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT00855595 Org: User:
Start: 02/28/09 End: 07/31/09 Due: 07/31/10

A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT03812198 Org: User:
Start: 01/22/19 End: 06/13/19 Due: 06/13/20

Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01320774 Org: User:
Start: 04/30/11 End: 01/31/12 Due: 01/31/13

TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction

Phase: N/A Priority: Normal
NCT ID: NCT04202445 Org: User:
Start: 04/30/14 End: 02/29/16 Due: 02/28/17

Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT03231124 Org: User:
Start: 07/25/17 End: 08/22/17 Due: 08/22/18

Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne

Phase: N/A Priority: Normal
NCT ID: NCT00031096 Org: User:
Start: 01/31/02 End: 07/31/02 Due: 07/31/03

Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00185510 Org: User:
Start: 03/31/05 End: 06/30/06 Due: 06/30/07

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00216879 Org: User:
Start: 02/28/05 End: 07/31/06 Due: 07/31/07

Investigation of Flare and Remission in Subjects With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03710044 Org: User:
Start: 01/14/19 End: 08/31/20 Due: 08/31/21

LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01143298 Org: User:
Start: 06/30/10 End: 09/30/10 Due: 09/30/11

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00248456 Org: User:
Start: 10/31/05 End: 02/28/06 Due: 02/28/07

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Phase: N/A Priority: Normal
NCT ID: NCT03725722 Org: User:
Start: 12/28/18 End: 05/19/20 Due: 05/19/21

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00263718 Org: User:
Start: 12/31/05 End: 05/31/06 Due: 05/31/07

Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT01703078 Org: User:
Start: 11/30/12 End: 04/30/13 Due: 04/30/14